Nathalie Ledee/LinkedIn
Sep 29, 2025, 11:50
Nathalie Ledee Highlights Emerging Insights from ESHRE 2025
Nathalie Ledee, Obstetrician Gynecologist and PhD, CEO at MatriceLab, shared a post on LinkedIn:
“It was a great pleasure to spend a whole day immersed in the exciting world of reproductive immunology at this wonderful, huge ESHRE2025 congress. It became clear that immunosuppressive therapies cannot be prescribed indiscriminately. Precision care requires a diagnosis. Another good news is that the concept that endometrial immune equilibrium may help weak embryos (while not being necessary for top-quality ones) is now emerging. Further studies will reveal more about this crucial issue.”
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now